Health-e-Connect: The FDA-Cleared System at the Forefront of Remote Diabetes Care
07 Outubro 2014 - 9:00AM
Access Wire
Richmond, VA / ACCESSWIRE / October 7, 2014 / ALR
Technologies' (ALRT) new FDA-cleared Remote Patient Monitoring
system may finally allow doctors and clinicians to receive
reimbursement for remote chronic care management, and it could
become one of the most influential platforms for managing diabetes.
ALRT's Health-e-Connect is the only off-the-shelf chronic care
system connecting diabetes patients with an experienced care team
as well their own physicians - anywhere in the country - through a
secure and trusted website. If the Centers for Medicare and
Medicaid Services (CMS) proposed payment schedule is finalized on
November 1, physicians would receive payments of $41.92 for up to
20 minutes of remote care each month.Implementation of the proposed
reimbursement plan would pave the way for ALRT to begin invoicing
and collecting revenue for its services for diabetes patients
covered by Medicare.Capturing just 1% of the US Medicare market as
it pertains to diabetes would represent up to $2.3 million per
month in potential revenue to ALRT.
This revenue-producing system could decrease long-term
healthcare costs, create compensation for physicians, and establish
positive cash flow for ALRT.The company moving towards the
revenue-generation stage is underscored by years of R&D and
millions of dollars in investment to achieve FDA clearance and meet
all HIPAA (Health Insurance Portability & Accountability Act)
requirements to ensure patient data confidentiality, a duo of
accomplishments that most potential competition has failed to
obtain.
This is a unique patient monitoring program that's made leaps
and strides in developing a profitable model for remote care for
patients with chronic disease. With the high global cost of
diabetes on the rise, ALRT is primed and positioned at the
forefront of the burgeoning Remote Patient Care industry. Its
system has already begun enrolling patients in the US in a bid to
prove its commercial viability and replicate data from clinical
trials demonstrating Health-e-Connect is influential in reducing
A1c levels, which can have a meaningful impact on clinical outcomes
in diabetes patients.
The Kansas City Metropolitan Physician Association (KCMPA), a
Medicare Accountable Care Organization, represents the first
large-scale commercial deployment of the Health-e-Connect remote
management system. The goal is to lower high-risk glucose levels of
some of KCMPA's most challenging diabetic patients. Importantly to
ALRT stakeholders, KCMPA has agreed to negotiate a fee to be paid
to ALRT for their use of the Health-e-Connect System beginning
January 1, 2015 if the proposed CMS reimbursement rule is
enacted.
"KCMPA is on the forefront of this wave of medical innovation,"
says ALRT President Bill Smith. With the system currently employed
in a major medical facility, the next step is for ALRT to expand
its model on a global scale.
"Diabetes is a huge issue. It's exploding in Latin America and
in Asia; it's really a public health pandemic that's affecting the
entire globe," Smith adds. 300 million people will be diagnosed
with diabetes by the year 2025, according to the American Diabetes
Association. The total cost of managing the disease in the US alone
is up to $245 billion, including $176 billion in direct medical
costs. Health-e-Connect addresses these costs by increasing
patient's remote involvement, which helps reduce A1c, the gold
standard in assessing diabetes control.
ALRT sits at the forefront of Remote Patient Monitoring with its
Health-e-Connect system.ALRT has created a remote monitoring and
patient care system that could allow physicians to draw down $41.92
per month for up to 20 minutes of remote care, whilst lowering the
massive global cost of diabetes care.Widespread adoption of the
ALRT diabetes management program by US physician groups could allow
ALRT and its investors to profit significantly from one of the most
innovative remote patient monitoring programs available in the US
market.
About ALR Technologies Inc.
ALR Technologies is a medical device company providing remote
monitoring and care facilitation for patients with chronic
diseases. ALRT has developed the FDA-cleared and HIPAA compliant
Health-e-Connect System that collects data from blood glucose
meters and uploads to a secure website. Trained Facilitators use
the System to effect efficiency of care among patients, clinicians
and caregivers to improve outcomes and assist health plans to
optimize their quality goals. Currently, the Company is focused on
diabetes and will expand its services to cover other chronic
diseases anchored on verifiable data.
Learn more about ALRT: http://www.glntv.tv/alrt
Recent national press coverage on the syndicated Good Life
Revolution radio show heard on the Wall Street Business Stations:
http://www.viralstocks.com/alr-technologies/
ALRT Homepage: http://alrt.com/
This release contains certain "forward-looking statements"
relating to ALR Technologies' business, and these statements
reflect the current views of ALR Technologies with respect to
future events and are subject to certain risks, uncertainties and
assumptions. When used, the words "estimate", "expect",
"anticipate", "believe" and similar expressions are intended to
identify such forward-looking statements. There are many factors
that could cause the actual results, performance or achievements of
ALR Technologies and its products to be materially different from
any future results, performances or achievements that may be
expressed or implied by such forward-looking statements. Further
management discussions of risks and uncertainties can be found in
the company's quarterly filings with the Securities
Exchange.
SOURCE: ALR Technologies Inc.
ALR Technologies (QB) (USOTC:ALRT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
ALR Technologies (QB) (USOTC:ALRT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024